U.S. Professional Services Stock News

NYSE:MCK
NYSE:MCKHealthcare

Analysts’ Backing of 2027 Targets Might Change The Case For Investing In McKesson (MCK)

In recent days, McKesson reported a mixed quarter but reinforced its long‑term plans, while major Wall Street banks reaffirmed positive views on the company’s outlook and multi-year guidance. At the same time, ongoing insider share sales and assessments of the stock as modestly overvalued have sharpened investor focus on how credible its fiscal 2027 ambitions really are. We’ll now examine how analysts’ support for McKesson’s fiscal 2027 guidance could influence the company’s existing...
NYSE:HP
NYSE:HPEnergy Services

How Investors Are Reacting To Helmerich & Payne (HP) Dividend, Asset Sale and Caspian Contract Renewal

Helmerich & Payne’s board on June 3, 2026, declared a quarterly cash dividend of US$0.25 per common share, payable on September 1 to shareholders of record as of August 18, alongside reporting a fiscal second-quarter net loss influenced by a non-cash impairment. The company also exceeded its asset divestiture goal with the sale of the Utica Square retail center and renewed a major Caspian Sea offshore operations and maintenance contract through its TURAN joint venture, reinforcing its focus...
NYSE:NOC
NYSE:NOCAerospace & Defense

If SpaceX’s Trillion Valuation Hits, These Space Giants Suffer

The SpaceX IPO hype is not just about one company; it is reshaping attention and capital around space and AI, and that can create both openings and pressure points for other stocks. With a US$75 billion offer for 5% of the company and a US$1.75 trillion valuation tied closely to its xAI ambitions, investors are suddenly rethinking which companies might lose out as money and headlines gravitate toward this new listing. This article highlights 3 stocks exposed to that news, each at risk of...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Extends Cystic Fibrosis Reach With Pediatric ALYFTREK And TRIKAFTA Data

Vertex Pharmaceuticals (NasdaqGS:VRTX) reported new clinical data for its next-generation cystic fibrosis therapy ALYFTREK in young children. The company also outlined progress on global regulatory submissions for ALYFTREK and TRIKAFTA in pediatric populations. The updates focus on expanding treatment access to children as young as 2 years old and on long term safety findings in older patients. Vertex Pharmaceuticals sits at the center of the cystic fibrosis treatment market, and the latest...
NYSE:NGL
NYSE:NGLOil and Gas

Why NGL Energy Partners (NGL) Is Down 7.0% After Swinging to Loss but Keeping Buybacks Running

NGL Energy Partners LP has reported past fourth-quarter 2026 revenue of US$949.51 million and a net loss of US$287.68 million, reversing from profit a year earlier and contributing to a full-year loss on lower annual revenue of US$3.16 billion. Despite this swing into loss, the partnership continued its unit repurchase program through March 2026, retiring about 6.71% of outstanding units for roughly US$49.56 million, which may influence how investors interpret management’s confidence and...
NasdaqGS:AEP
NasdaqGS:AEPElectric Utilities

A Look At American Electric Power Company (AEP) Valuation After OVEC Overhaul And Data Center Growth Plans

American Electric Power Company (AEP) has just completed a Federal Energy Regulatory Commission approved overhaul of its Ohio Valley Electric Corporation interests, shifting power entitlements and equity stakes within the group. For investors, this regulatory milestone reframes how to think about AEP’s risk profile and capital priorities. See our latest analysis for American Electric Power Company. At a share price of $126.77, AEP has eased 1.8% over the past day but still sits on a 9.5% year...
NYSE:SR
NYSE:SRGas Utilities

Does Spire's Lower 2026 Outlook And Massive Capex Plan Reshape The Bull Case For SR?

In its recently reported fiscal 2026 second quarter, Spire Inc. posted adjusted earnings of US$3.76 per share with year-over-year revenue contraction and updated its full-year adjusted earnings guidance to a range below earlier market expectations. Alongside the softer near-term outlook, Spire outlined US$11.20 billion of planned capital investments through fiscal 2035, signaling a significant long-horizon build-out of its regulated infrastructure base. Next, we’ll examine how the lowered...
NasdaqGS:DNUT
NasdaqGS:DNUTHospitality

Exploring Undervalued Small Caps With Insider Activity In June 2026

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with projected annual earnings growth of 17%. In this fluctuating environment, identifying small-cap stocks that are undervalued and exhibit insider activity can present unique opportunities for investors seeking to capitalize on potential market inefficiencies.
NYSE:NIC
NYSE:NICBanks

June 2026's Top Stocks Estimated To Be Below Fair Value

Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this context, identifying stocks that are estimated to be below their fair value can present opportunities for investors looking to capitalize on potential growth amid current market fluctuations.
NasdaqCM:IMMX
NasdaqCM:IMMXBiotechs

Exploring 3 High Growth Tech Stocks in the US Market

Over the last 7 days, the United States market has dropped 2.7%, yet it remains up by 23% over the past year, with earnings forecasted to grow by 17% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that exhibit strong innovation potential and robust financial health to capitalize on future opportunities.
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

3 Growth Stocks With High Insider Ownership And 29% Revenue Growth

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer unique insights into potential opportunities as insiders may have confidence in their company's future prospects and are often aligned with shareholder interests.
NasdaqGS:SGHT
NasdaqGS:SGHTMedical Equipment

Discover 3 Promising Penny Stocks With Market Caps Over $20M

Over the last 7 days, the U.S. market has dropped by 2.7%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. For investors interested in smaller or newer companies, penny stocks — despite being an older term — remain relevant as they can offer surprising value and growth potential when backed by strong financials. This article highlights several penny stocks that stand out for their financial strength, presenting opportunities for those seeking...
NasdaqGS:LKFN
NasdaqGS:LKFNBanks

3 Reliable Dividend Stocks Offering At Least 3.4% Yield

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this dynamic environment, reliable dividend stocks offering yields of at least 3.4% can provide a stable income stream while potentially benefiting from overall market growth.
NasdaqGM:CD
NasdaqGM:CDCapital Markets

If OpenAI’s IPO Reshapes Markets These IPO Stocks Could Jump

OpenAI’s confidential plan to go public at a potential valuation above $1t is not just a headline; it is a possible reset moment for how markets think about fast growing AI platforms and the companies around them. If investor appetite for this IPO is strong, it could influence pricing, expectations and capital flows across newer listings. This article highlights 3 stocks from our IPO Investment Opportunities screener that are exposed to this news in different ways, helping you decide whether...
NYSE:AD
NYSE:ADWireless Telecom

Does Array’s US$11 Special Dividend Amid Cash Strains Reshape The Bull Case For AD?

Array Digital Infrastructure, Inc. recently declared a special dividend of US$11.00 per Common and Series A Common Share, payable on June 25, 2026 to shareholders of record as of June 11, 2026. This one-time cash return comes as the company balances tower optimization and spectrum initiatives with ongoing revenue pressure and weaker free cash flow. Now we will examine how this sizeable special dividend, alongside ongoing operational headwinds, shapes Array Digital Infrastructure’s investment...
NYSE:MKL
NYSE:MKLInsurance

Will JANA’s Divestiture Push and New Fine Art Lead Markel Group (MKL) to Refocus Its Core?

Markel Group Inc. recently appointed Danny O'Donoghue as head of Fine Art Specie, effective May 27, 2026, with the role based in London to guide the expansion of this specialist portfolio. This hire, alongside activist investor JANA Partners urging divestitures and a large tender offer, highlights mounting pressure on how Markel balances specialty insurance focus with its diversified Ventures operations. Next, we’ll examine how JANA’s push for divestitures and capital returns could reshape...